Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
24.14
-0.45 (-1.83%)
Jun 5, 2026, 12:51 PM EDT - Market open
Definium Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +44.99% | May 21, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $38 | Buy | Maintains | $38 | +57.42% | May 16, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +189.98% | May 13, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $40 | Buy | Maintains | $40 | +65.70% | May 12, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $61 | Buy | Reiterates | $61 | +152.69% | May 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $36 | Buy | Maintains | $36 | +49.13% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $38 | Buy | Reiterates | $38 | +57.42% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $49 → $48 | Buy | Reiterates | $49 → $48 | +98.84% | May 8, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.